Technology

SMSGOP and SMGOP are two models of artificial intelligence that can predict progression of Graves’ orbitopathy.

Technology offers accessibility, scalability to countries where care is needed the most.

Evolving technology is resulting in better outcomes for patients.

Nitish Mehta, MD discusses the latest trends in Artificial Intelligence and Machine Learning technology in retinal imaging and its uses for ophthalmologists.

Physician discusses preoperative assessments before procedure focusing on cornea.

The new laser will allow surgeons to perform refractive correction on patients with myopia, with or without astigmatism using the SILK Procedure.

Artificial intelligence (AI) with ultra-widefield fundus autofluorescence images may be helpful to objectively estimate progression of retinitis pigmentosa (RP) and visual function.

Having the best tools available is of the utmost importance in the operating room (OR).

According to the company, the app features new content, including podcasts, discussion forums and downloadable content for eyecare professionals.

Physician discusses existing advancements, innovations for treatment.

Bausch + Lomb and Modulight announce the photodynamic laser for use with photodynamic therapy was approved by the FDA for the treatment of patients with subfoveal choroidal neovascularization due to AMD.

With donations, the West Virginia University Department of Ophthalmology and Visual Sciences has added two new pieces of ophthalmic training equipment to its lab.

Researchers are looking for improved detection of disease in patients.

Runa Capital-led funding will help scale the AI-powered eye pathology detection solution.

Discovery CORE and its AI models have been designed to accelerate data analysis and help clinical and academic researchers collaborate more efficiently in real time with their peers on medical and imaging datasets.

In a two-decade career as a researcher at Johnson & Johnson Surgical Vision, Piers has been a part of teams at the forefront of a number of innovations in IOLs. She discusses her career and the outlook for research and development in ophthalmology.

Patients surveyed say the handheld tool proved to be comfortable and easy to use.

The SBL-3 ClearView clinical study, an FDA investigational device exemption clinical trial conducted at 18 sites across the US, is a prospective, subject-masked, randomized, two-arm study.

The company is rolling out the Biovance 3L ocular tri-layer human amniotic membrane.

According to the company, ROP Check builds upon its pediatric retina screening portfolio, adding digital management (schedule, document, bill, and transfer) for treating patients with retinopathy of prematurity.

The screening of diabetics for retinopathy has recently become reimbursable in the US, the company noted in its news release, and the approval comes after positive Phase 3 clinical trial earlier this year.

By placing the chin on the chinrest, Nidek’s NT-1p automatically detects the position of the eyes and begins measurement without pressing any buttons.

Ferdinand-Braun-Institute in Berlin, Germany is developing a solution with its semiconductor-based laser sources.

The company's AI cloud-based platform is available via a browser to any eye care professional in the world. The artificial intelligence algorithm was trained on millions of graphically labeled OCT scans collected from ophthalmic clinics.

The EyeBuddy app will bring telehealth to eye doctors in the coming months, connecting patients across Bangladesh with ophthalmologists at a major eye-care hospital.

CEO Rob Thornhill discusses the features of the device, as well as plans for a new technology called ZEPTOLINK which combines the company’s novel ZEPTO technology with any phaco device.

Harit Bhatt, MD, a Chicagoland-area retinal surgeon, shared his experience with the LEAF and LION portable lasers during a conversation at the American Academy of Ophthalmology’s 2022 annual meeting in Chicago.

According to Mark Packer, MD, FACS, observations include key data points and clinical implications.

Anterior segment surgeon expands on the use of the XtraFocus pinhole implant.

NovaSight’s CureSight is a digital device that proved in a pivotal study to be non-inferior to patching, according to the company.